On the Renewal of the Sale of „Corhydron“

SANITAS 	STOCK EXCHANGE RELEASE	18.01.2007.		

On the Renewal of the Sale of „Corhydron“ 

On the basis of the decision of January 17, 2007 made by 
Polish General Pharmaceutical Inspection, the sale 
of „Corhydron“ 100 and „Corhydron“ 25 – medicine, 
manufactured by Jelfa was renewed. This decision was made 
after pharmaceutical inspectors had investigated all 
documentation and records of manufacturing and 
packing of the said product, the procedures of cleaning 
of manufacturing premises and production lines, took into 
account their efficiency. The investigation proved the 
fact that there was no possibility of contaminating 
„Corhydron” with other substances in the process 
of its manufacturing. The sale of „Corchydron“ 250 
was renewed earlier on.


Head of Legal and general issues department		
Ruta Milkuviene			                    
+370 37 20 06 62